Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
DeepCure
DeepCure discovers and develops novel small-molecule therapies for immune and inflammatory diseases using AI to shorten the drug discovery timeline. The company operates a B2B SaaS-style drug…
DeepCure
DeepCure discovers and develops novel small-molecule therapies for immune and inflammatory diseases using AI to shorten the drug discovery timeline. The company operates a B2B SaaS-style drug…
TL;DR
What they do: AI-driven discovery and development of small-molecule therapies for immune and inflammatory diseases
Product: Inspired Chemistry platform combining deep learning, reinforcement learning, physics-based modeling and automated synthesis
Stage & financing: Multiple venture rounds including a Series A; total funding reported around $47M–$71.4M with a Series A announced Apr 11, 2024
HQ & founded: Boston, MA; founded 2018
Team size: Approximately 29 employees
Company Overview
Problem Domain
Small-molecule drug discovery for immune and inflammatory diseases
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Latest Series A announced Apr 11, 2024 (multiple sources report a $40M Series A and total funding figures ranging around $47M; a total funding amount of $71.4M is also present in records)
Investor Signal
“IAG Capital Partners; Morningside; Sapir Venture Partners; TLV Partners; E14 Fund; Benon Group; Creative Destruction Lab”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |